Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

An estimated one in three people report regular sleep complaints. So it’s hardly surprising people are more concerned than ever about getting enough sleep. This blossoming interest has seen an explosion of sleep trackers which measure how many hours of sleep you get each night. But these devices may not be as accurate or useful as they claim.

As we sleep, we go through cycles of “deep”, “light” and “rapid eye movement” (REM) sleep. The “deep” portion of our sleep is mainly what leaves us feeling refreshed the next day. Most sleep trackers are a watch worn on the wrist, and work by monitoring your body movements as you sleep to determine how much time you probably spent awake versus asleep. Some devices also look at heart rate changes during sleeping to estimate how much time you spent in each sleep cycle.

Read the full article on The Conversation website, written by Matthew Reid, Nuffield Department of Clinical Neurosciences.

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Potential for radiotherapy and VTP multimodality therapy for prostate cancer

A recent collaborative study from the University of Oxford has investigated the potential benefit of a combined therapy approach to prostate cancer treatment, using radiotherapy and vascular targeted photodynamic therapy (VTP), which could lead to first-in-man early phase clinical trials.

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Oxford University and partners win government funding to evaluate Paige Prostate Cancer Detection System

A prostate cancer detection software system to help pathologists quickly identify suspicious areas of tissue, developed by Paige, will be investigated in a multicentre clinical study led by Oxford University as part of a successful NHSx Artificial Intelligence Health and Care Award application.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.